What Does Generic Lyrica Mean for MSAs?
Posted on July 31, 2019 by Tower MSA Partners
On July 19, 2019, the Food and Drug Administration (FDA) approved multiple applications for the first generics of Lyrica (pregabalin). This follows the expiration of Pfizer’s patent on Lyrica at the end of June. The generic is expected to be…
NAMSAP Provides Unique Opportunity to Expand Your Medicare Compliance Knowledge
Posted on July 29, 2019 by Tower MSA Partners
Through our quarterly webinars and in-person trainings, Tower offers our partners recent and relevant information combined with best practices in Medicare Secondary Payer compliance. However, once a year, a unique opportunity is presented by the National Alliance of Medicare Set-Aside…
METRICS, MSAS & SETTLEMENT STRATEGIES AT WCI2019
Posted on July 26, 2019 by Tower MSA Partners
Tower’s Dan Anders and American Airline’s Kris Sallee will present during two panels at WCI this year. Starting at 9 a.m. on Aug. 14, “Optimizing Settlement Outcomes by Measuring and Managing MSA Costs” stresses the importance of determining and using…
Posted on July 2, 2019 by Tower MSA Partners
Why does CMS do what they do when it comes to MSAs? Many a claims professional and injured worker have probably pondered this question. Well, the wait for answers is over. On July 24, 2019 at 2 pm ET, Tower…
Search our blog:
Contact Us for a FREE Consultation